Adaptive Biotechnologies (ADPT) Gains from Investment Securities (2019)
Adaptive Biotechnologies (ADPT) posted Gains from Investment Securities of $2.2 million for Q2 2019, up 12388.89% sequentially from $18000.0 in Q1 2019.
Adaptive Biotechnologies (ADPT) Gains from Investment Securities (2019) Analysis & Trends
Adaptive Biotechnologies has reported Gains from Investment Securities for 1 years, with the latest figure at $2.2 million in Q2 2019.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $2.2 million in Q2 2019, while the trailing twelve-month figure through Dec 2019 was $2.3 million (changed N/A YoY) and the FY2019 annual result came in at $2.3 million, up 37866.67% from the prior year.
- Gains from Investment Securities advanced to $2.2 million in Q2 2019 per ADPT's latest filing, from $18000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $2.2 million in Q2 2019 and troughed at $18000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 2.25 Mn |
| Jun 30, 2019 | 2.25 Mn |
| Mar 31, 2019 | 18,000.00 |
| Mar 31, 2019 | 18,000.00 |